Login / Signup

ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.

Hanxi YiWangxing LuFan LiuGuoqing ZhangFeifan XieWenjie LiuLei WangWenhu ZhouZe-Neng Cheng
Published in: Journal of nanobiotechnology (2021)
Lipo/pB-DOX/ICG is a novel tool for on-demand drug release at tumor site and also a promising candidate for controllable and accurate combinatorial tumor therapy.
Keyphrases
  • drug release
  • drug delivery
  • cancer therapy
  • cell death
  • heavy metals
  • fluorescence imaging
  • stem cells
  • photodynamic therapy
  • oxidative stress
  • bone marrow
  • smoking cessation
  • mesenchymal stem cells
  • fluorescent probe